Young Kwang Chae, Medical Oncologist, Translational Physician-Scientist, Professor, Co-Director of Developmental Therapeutics, Lurie Cancer Center at Northwestern University, shared a post on X:
“Congrats to the FLAURA2 team and Dr. Nabil Chehab! Final mOS: 47.5 vs 37.6 mo (HR 0.77)! Wondering if this holds without maintenance chemo (median pemetrexed 11 cycles).”
More from Young Kwang Chae on OncoDaily.
